NIP
TRIB

Nicholas Investment Partners’s Trinity Biotech TRIB Stock Holding History

Nicholas Investment Partners’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,000
Closed -$183K – 316
2014
Q3 		$183K Sell
2,000
-11,853
-86% -$1.28M 0.01% 296
2014
Q2 		$1.59M Buy
13,853
+309
+2% +$36.6K 0.09% 252
2014
Q1 		$1.64M Buy
+13,544
New +$1.78M 0.14% 245

Other funds holding TRIB

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Nicholas Investment Partners's TRIB Position: Q4 2014 in Review

Nicholas Investment Partners sold out of Trinity Biotech (TRIB) in Q4 2014, closing a stake of 2,000 shares — an estimated $183K sold.

Nicholas Investment Partners first reported a position in TRIB in Q1 2014 and held it in 3 quarters. The position peaked at $1.64M in Q1 2014. 92 funds tracked by Wall St. Rank hold TRIB as of Q4 2014.

  • Nicholas Investment Partners reported no remaining Trinity Biotech position as of Q4 2014 after selling out during the quarter.
  • Nicholas Investment Partners sold 2,000 Trinity Biotech shares in Q4 2014, an estimated $183K.
  • Nicholas Investment Partners first reported a position in Trinity Biotech in Q1 2014 and held it in 3 quarters.
  • Nicholas Investment Partners's Trinity Biotech position peaked at $1.64M in Q1 2014.
  • 92 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2014.

Based on Nicholas Investment Partners's 13F filing for Q4 2014, filed 17 Feb 2015.